BRYCE RICHARD PAUL

CIK 00015530373 companiesLOS ANGELES, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001553037

Recent Transactions

50 trades

Award
enGene Holdings Inc.$ENGN
Stock Option (Right to Buy)
2023-11-30+153,000→ 153,000 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2023-02-15+110,000→ 110,000 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2022-01-07+53,064→ 53,064 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2021-04-05$9.80/sh−426→ 121,662 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2021-03-02$10.15/sh−422→ 122,088 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2021-02-17+52,846→ 122,510 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2021-02-17+74,341→ 74,341 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2021-02-02$12.23/sh−415→ 69,664 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2021-01-04$10.23/sh−6,548→ 70,079 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-12-02$11.65/sh−92→ 76,627 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-11-02$7.81/sh−97→ 76,719 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-10-02$10.14/sh−91→ 76,816 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-09-02$9.77/sh−90→ 76,907 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-08-03$10.80/sh−86→ 76,997 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-07-02$10.67/sh−660→ 77,083 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-06-02$10.66/sh−89→ 77,743 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-05-04$9.62/sh−89→ 77,832 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-04-02$7.37/sh−91→ 77,921 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-03-02$10.02/sh−96→ 78,012 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2020-02-11+54,842→ 54,842 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-02-11+43,274→ 78,108 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-02-03$8.02/sh−105→ 34,834 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-01-02$8.36/sh−2→ 36,453 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2020-01-02$8.40/sh−1,514→ 34,939 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-12-02$10.34/sh−83→ 36,455 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-11-04$7.38/sh−88→ 36,538 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-10-02$10.05/sh−91→ 36,626 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-09-04$10.11/sh−95→ 36,717 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-08-02$9.00/sh−94→ 36,812 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-07-22$10.10/sh−1,841→ 36,906 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-07-02$12.78/sh−89→ 38,747 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-06-03$15.07/sh−88→ 38,836 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-05-02$32.38/sh−85→ 38,924 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-04-02$35.78/sh−88→ 39,009 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-03-04$38.66/sh−88→ 39,097 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2019-02-06+15,400→ 15,400 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-02-06+9,900→ 39,185 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-02-04$27.77/sh−89→ 29,285 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-01-22$24.72/sh−1,959→ 29,374 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2019-01-03$20.67/sh−1,210→ 31,333 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2018-07-20$51.95/sh−1,836→ 32,543 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2018-02-11+9,000→ 34,379 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2018-02-11−9,000→ 34,379 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2018-02-11+14,000→ 14,000 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2018-01-22$92.75/sh−1,860→ 25,379 total
Exercise/Conversion
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2017-09-29$11.30/sh+15,000→ 42,239 total
Exercise/Conversion
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2017-09-29−15,000→ 67,000 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2017-09-29$120.00/sh−15,000→ 27,239 total
Exercise/Conversion
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2017-09-07−14,000→ 82,000 total
Exercise/Conversion
PUMA BIOTECHNOLOGY, INC.$PBYI
COMMON STOCK
2017-09-07$11.30/sh+14,000→ 41,239 total

Companies

Recent Filings

Address

C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BLVD., SUITE 2150

LOS ANGELES, CA, 90024

View on SEC.gov